As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE Life Sciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces the appointment of Dr. Deepak “Dee” Khuntia, M.D., FASTRO, to its esteemed Board of Directors. Dr. Khuntia brings unparalleled expertise and invaluable insights to the board, further strengthening TAE Life Sciences’ position as a pioneer in the field of radiation oncology. As Senior Vice President of Medical Affairs and
The post TAE Life Sciences Welcomes Dr. Deepak “Dee” Khuntia to Its Board of Directors appeared first on Pharma Mirror Magazine.
